Table.
Subject Demographics
| Group and Patient No. | Sex | MMSE Score | PiB Retention Status |
|---|---|---|---|
| Control subjectsa | |||
| C-1 | F | 29 | Negative |
| C-2 | M | 28 | Positive |
| C-3 | M | 30 | Negative |
| C-4 | F | 30 | Positive |
| C-5 | M | 30 | Negative |
| Patients with MCIb | |||
| M-1 | M | 29 | Positive |
| M-2 | F | 29 | Negative |
| M-3 | M | 30 | Positive |
| M-4 | F | 29 | Positive |
| M-5 | M | 27 | Negative |
| M-6 | M | 28 | Positive |
| Patients with ADc | |||
| A-1 | M | 19 | Positive |
| A-2 | F | 28 | Positive |
| A-3 | F | 19 | Positive |
| A-4 | M | 19 | Positive |
| A-5 | M | 13 | Positive |
| A-6 | M | 18 | Positive |
Abbreviations: AD, Alzheimer disease; MCI, mild cognitive impairment; MMSE, Mini-Mental State Examination; PiB, Pittsburgh Compound B.
a
The mean (SD) age was 72.0 (5.9) years and the age range was 65 to 79 years.
b
The mean (SD) age was 71.8 (8.5) years and the age range was 61 to 80 years.
c
The mean (SD) age was 76.5 (10.5) years and the age range was 65 to 94 years.